Year |
Citation |
Score |
2013 |
Liu Y, Conaway L, Rutherford Bethard J, Al-Ayoubi AM, Thompson Bradley A, Zheng H, Weed SA, Eblen ST. Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion. Nucleic Acids Research. 41: 4949-62. PMID 23519612 DOI: 10.1093/Nar/Gkt170 |
0.71 |
|
2012 |
Al-Ayoubi AM, Zheng H, Liu Y, Bai T, Eblen ST. Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion. Molecular and Cellular Biology. 32: 2880-93. PMID 22615491 DOI: 10.1128/Mcb.06327-11 |
0.73 |
|
2011 |
Liu Y, Al-Ayoubi A, Zheng H, Bethard J, Eblen ST. Abstract 3077: The SR protein kinase Clk1 phosphorylates SPF45 and regulates its localization, degradation and alternative splicing activity Cancer Research. 71: 3077-3077. DOI: 10.1158/1538-7445.Am2011-3077 |
0.709 |
|
2010 |
Zheng H, Al-Ayoubi A, Eblen ST. Identification of novel substrates of MAP Kinase cascades using bioengineered kinases that uniquely utilize analogs of ATP to phosphorylate substrates. Methods in Molecular Biology (Clifton, N.J.). 661: 167-83. PMID 20811983 DOI: 10.1007/978-1-60761-795-2_10 |
0.684 |
|
2009 |
Li Q, Al-Ayoubi A, Guo T, Zheng H, Sarkar A, Nguyen T, Eblen ST, Grant S, Kellogg GE, Zhang S. Structure-activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: development of potential substrate-specific ERK1/2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19: 6042-6. PMID 19796943 DOI: 10.1016/J.Bmcl.2009.09.057 |
0.644 |
|
2008 |
Al-Ayoubi A, Tarcsafalvi A, Zheng H, Sakati W, Eblen ST. ERK activation and nuclear signaling induced by the loss of cell/matrix adhesion stimulates anchorage-independent growth of ovarian cancer cells. Journal of Cellular Biochemistry. 105: 875-84. PMID 18726893 DOI: 10.1002/Jcb.21889 |
0.66 |
|
Show low-probability matches. |